SCHEMBL20076015

SCHEMBL20076015

Cc1nc2[nH]c(-c3ccco3)cc(=O)n2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.45
ADORA1 P30542 2/20 0.45
NPY5R Q15761 1/20 0.42
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 3/20 0.41
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
GSK3B P49841 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20075849 0.78 ALDH1A1 (0.51) ADORA2AADORA1NPY5RKDM4EALDH1A1
SCHEMBL20076013 0.76 PIK3C3 (0.37) ADORA1KDM4EALDH1A1RAB9AMAPT
SCHEMBL20074202 0.76 POLB (0.47) ADORA2AADORA1KDM4EALDH1A1CTSV
SCHEMBL20076008 0.74 KDM4E (0.46) NPY5RKDM4EALDH1A1RAB9APOLB
SCHEMBL20076038 0.74 ADORA2A (0.47) ADORA2AADORA1NPY5RALDH1A1ADORA3
SCHEMBL20076033 0.74 TP53 (0.47) NPY5RKDM4EALDH1A1RAB9AMEN1
SCHEMBL12952980 0.73 CCNB2 (0.47) ADORA2AADORA1KDM4EALDH1A1CTSV
SCHEMBL20076032 0.73 NPC1 (0.45) KDM4EALDH1A1RAB9AMEN1POLB
SCHEMBL20076012 0.73 KDM5B (0.39) ADORA2AADORA1KDM4EALDH1A1KMT2A
SCHEMBL20076009 0.73 ALDH1A1 (0.45) ADORA2AADORA1NPY5RKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048259-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US claimed
US-20200048259-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
US-20200048259-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
WO-2018071282-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048259-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C ADORA2A 3979/4885ADORA1 3457/4885NPY5R 457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.